| MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy RV Lalla, J Bowen, A Barasch, L Elting, J Epstein, DM Keefe, DB McGuire, ... Cancer 120 (10), 1453-1461, 2014 | 1193 | 2014 |
| Emerging evidence on the pathobiology of mucositis N Al-Dasooqi, ST Sonis, JM Bowen, E Bateman, N Blijlevens, RJ Gibson, ... Supportive care in cancer 21, 2075-2083, 2013 | 321 | 2013 |
| Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease? R Yazbeck, GS Howarth, CA Abbott Trends in pharmacological sciences 30 (11), 600-607, 2009 | 286 | 2009 |
| Systematic review of agents for the management of gastrointestinal mucositis in cancer patients RJ Gibson, DMK Keefe, RV Lalla, E Bateman, N Blijlevens, M Fijlstra, ... Supportive Care in Cancer 21, 313-326, 2013 | 249 | 2013 |
| Lactobacillus fermentum BR11 and Fructo-Oligosaccharide Partially Reduce Jejunal Inflammation in a Model of Intestinal Mucositis in Rats CL Smith, MS Geier, R Yazbeck, DM Torres, RN Butler, GS Howarth Nutrition and Cancer 60 (6), 757-767, 2008 | 150 | 2008 |
| Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis RJ Lindsay, MS Geier, R Yazbeck, RN Butler, GS Howarth British Journal of Nutrition 104 (4), 513-519, 2010 | 101 | 2010 |
| Grape seed extract protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis. KY Cheah, GS Howarth, R Yazbeck, TH Wright, EJ Whitford, C Payne, ... Cancer Biology & Therapy 8 (4), 382-390, 2009 | 94 | 2009 |
| Effects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent, 5-Fluorouracil (5-FU) EJ Whitford, AG Cummins, RN Butler, LD Prisciandaro, JK Fauser, ... Cancer biology & therapy 8 (6), 505-511, 2009 | 73 | 2009 |
| The herbal extract Iberogast® improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositis TH Wright, R Yazbeck, KA Lymn, EJ Whitford, KY Cheah, RN Butler, ... Cancer biology & therapy 8 (10), 923-929, 2009 | 66 | 2009 |
| Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice R Yazbek, G Howarth, M Geier, H Demuth, C Abbott Frontiers in Bioscience, 2008 | 64 | 2008 |
| Dipeptidyl peptidase expression during experimental colitis in mice R Yazbeck, ML Sulda, GS Howarth, A Bleich, K Raber, S von Hörsten, ... Inflammatory bowel diseases 16 (8), 1340-1351, 2010 | 59 | 2010 |
| Growth factor based therapies and intestinal disease: is glucagon-like peptide-2 the new way forward? R Yazbeck, GS Howarth, CA Abbott Cytokine & growth factor reviews 20 (2), 175-184, 2009 | 56 | 2009 |
| Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis R Yazbeck, GS Howarth, RN Butler, MS Geier, CA Abbott Journal of cellular physiology 226 (12), 3219-3224, 2011 | 51 | 2011 |
| Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV MS Geier, D Tenikoff, R Yazbeck, GW McCaughan, CA Abbott, ... Journal of Cellular Physiology 204 (2), 687-692, 2005 | 51 | 2005 |
| From blood to breath: New horizons for esophageal cancer biomarkers R Yazbeck, SE Jaenisch, DI Watson World journal of gastroenterology 22 (46), 10077, 2016 | 43 | 2016 |
| Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein R Yazbeck, SE Jaenisch, CA Abbott Protoplasma 255, 375-386, 2018 | 40 | 2018 |
| The use of selected ion flow tube-mass spectrometry technology to identify breath volatile organic compounds for the detection of head and neck squamous cell carcinoma: a pilot … D Chandran, EH Ooi, DI Watson, F Kholmurodova, S Jaenisch, ... Medicina 55 (6), 306, 2019 | 28 | 2019 |
| Mucositis Study Group of Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Emerging evidence on the pathobiology of … N Al-Dasooqi, ST Sonis, JM Bowen, E Bateman, N Blijlevens, RJ Gibson, ... Support Care Cancer 21 (7), 2075-83, 2013 | 28 | 2013 |
| Dipeptidyl peptidase 4 inhibitors: Applications in innate immunity? R Yazbeck, SE Jaenisch, CA Abbott Biochemical Pharmacology 188, 114517, 2021 | 27 | 2021 |
| Prebiotics Fructo-, Galacto-, and Mannan-Oligosaccharide Do Not Protect against 5-Fluorouracil–Induced Intestinal Mucositis in Rats R Yazbeck, RJ Lindsay, MS Geier, RN Butler, GS Howarth The Journal of nutrition 149 (12), 2164-2173, 2019 | 25 | 2019 |
Gordon HowarthProfessor of Gastrointestinal Physiology, University of AdelaideVerified email at adelaide.edu.au
